Dr. Robert Whitfield explains why fat transfer fails in patients with chronic inflammation: the transferred fat doesn't integrate and hardens or calcifies instead. Good candidates have low systemic inflammation and a healthy cellular environment. He developed the SHARP method to metabolically optimize patients before surgery and improve graft survival.
Now, if you take someone, think, who's medically inflamed— I'm sorry, who is chronically inflamed, metabolically compromised, and you move the fat from one place to another, whether it's your breast, face, butt, what do you think happens? Well, a portion of it will fail because your body's not ready to transfer it. Your body's not ready to accept it. It doesn't really integrate, and that becomes the issue, and you end up with hardness, maybe calcification, maybe cyst formation, all these things. And it's not what you're looking for, which is soft, nice results. So who is a good candidate? And a good candidate is someone whose systemic inflammation is under control, somebody who has good cellular health, um, and someone who understands that we are not moving tissue. We are— we're going to transplant something and we want to heal with its friends in the right space, like the fatty friends. So Going back to her, who was already a really good candidate from a metabolic standpoint, if you're not metabolically optimized, you're not gonna be a candidate yet. That word yet is because that's the whole nature of the SHARP method is to help prepare people 'cause that's exactly what the system is designed to do and designed to help with and rectify.
